TQH-2722 is a humanized IgG4 anti-IL-4Ralpha monoclonal antibody. TQH-2722 targets the IL-4Ralpha receptor in humans, effectively disrupting the interaction between IL-4Ralpha and the downstream cytokines IL-4 and IL-13, thereby inhibiting inflammatory response. TQH-2722 can be used for the study of atopic dermatitis (AD) and chronic rhinosinusitis with nasal polyps (CRSwNP)[1].
Target:
Interleukin Related
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted
